Sheridan William P
Insider CIK 1439174 · BCRX Senior VP - CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2022-03-10 | 2022-03-14 | 148,302 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-03-10 | 2022-03-14 | 1,400 | $17.64 | $24.7K | 37,954 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2022-03-10 | 2022-03-14 | 148,302 | $3.22 | $477.5K | 199,093 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2022-03-10 | 2022-03-14 | 159,739 | $16.87 | $2.69M | 39,354 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-12-14 | 2021-12-16 | 164,000 | — | $0 | 164,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-12-14 | 2021-12-16 | 35,000 | — | $0 | 50,791 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-28 | 2021-06-01 | 64,299 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-28 | 2021-06-01 | 21,614 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-28 | 2021-06-01 | 5,901 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-05-28 | 2021-06-01 | 91,814 | $15.02 | $1.38M | 14,475 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-28 | 2021-06-01 | 21,614 | $4.73 | $102.2K | 36,089 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-28 | 2021-06-01 | 64,299 | $5.59 | $359.4K | 100,388 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-28 | 2021-06-01 | 5,901 | $5.45 | $32.2K | 106,289 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-27 | 2021-06-01 | 35,701 | — | $0 | 64,299 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-27 | 2021-06-01 | 24,959 | — | $0 | 21,614 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-05-27 | 2021-06-01 | 11,099 | — | $0 | 5,901 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-27 | 2021-06-01 | 35,701 | $5.59 | $199.6K | 75,135 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-27 | 2021-06-01 | 11,099 | $5.45 | $60.5K | 86,234 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-05-27 | 2021-06-01 | 71,759 | $15.00 | $1.08M | 14,475 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-05-27 | 2021-06-01 | 24,959 | $4.73 | $118.1K | 39,434 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2021-02-22 | 2021-02-24 | 41,250 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2021-02-22 | 2021-02-24 | 41,250 | $11.57 | $477.3K | 11,475 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2021-02-22 | 2021-02-24 | 41,250 | $4.15 | $171.2K | 52,725 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-15 | 2020-12-17 | 335,000 | — | $0 | 335,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-12-03 | 2020-12-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-21 | 2020-02-25 | 22,600 | — | $0 | 22,600 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-02-14 | 2020-02-19 | 39,550 | — | $0 | 39,550 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-12-17 | 2019-12-19 | 176,000 | — | $0 | 176,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2019-01-01 | 2019-01-03 | 1,087 | $8.07 | $8.8K | 1,638 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2018-12-20 | 2018-12-21 | 335,000 | — | $0 | 335,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-12-18 | 2018-12-20 | 20,488 | $7.58 | $155.3K | 2,725 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-08-09 | 2018-08-13 | 62,500 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-08-09 | 2018-08-13 | 62,500 | $1.42 | $88.8K | 85,713 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-08-09 | 2018-08-13 | 62,500 | $7.03 | $439.4K | 23,213 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2018-06-01 | 2018-06-05 | 42,112 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2018-06-01 | 2018-06-05 | 42,112 | $2.58 | $108.6K | 63,170 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2018-06-01 | 2018-06-05 | 42,112 | $6.30 | $265.3K | 21,058 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-20 | 2018-01-23 | 4,628 | $5.59 | $25.9K | 18,058 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2018-01-01 | 2018-01-03 | 1,169 | $4.91 | $5.7K | 22,686 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-12-20 | 2017-12-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2017-11-13 | 2017-11-15 | 64,310 | $4.72 | $303.5K | 23,855 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-08-31 | 2017-09-05 | 33,900 | — | $0 | 33,900 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2017-02-27 | 2017-03-01 | 175,000 | — | $0 | 175,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-20 | 2017-01-24 | 5,761 | $5.95 | $34.3K | 82,916 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2017-01-01 | 2017-01-03 | 2,081 | $6.33 | $13.2K | 88,677 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2016-05-23 | 2016-05-25 | 148,302 | — | $0 | 148,302 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-03-01 | 2016-03-03 | 799 | $2.13 | $1.7K | 90,052 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-20 | 2016-01-22 | 5,359 | $7.55 | $40.5K | 88,967 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2016-01-01 | 2016-01-05 | 2,081 | $10.32 | $21.5K | 94,326 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-12-29 | 2015-12-31 | 71,698 | — | $0 | 71,698 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2015-06-19 | 2015-06-22 | 70,389 | — | $0 | 42,112 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2015-06-19 | 2015-06-22 | 70,389 | $1.20 | $84.5K | 165,512 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2015-06-19 | 2015-06-22 | 70,389 | $15.05 | $1.06M | 95,123 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-05-13 | 2015-06-16 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-03-01 | 2015-03-03 | 1,739 | $10.20 | $17.7K | 95,123 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-20 | 2015-01-22 | 5,074 | $11.17 | $56.7K | 95,609 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2015-01-01 | 2015-01-05 | 52,000 | — | $0 | 52,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2015-01-01 | 2015-01-05 | 2,735 | $12.16 | $33.3K | 100,683 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2015-01-01 | 2015-01-05 | 10,900 | — | $0 | 103,418 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-12-30 | 2014-12-31 | 23,104 | — | $0 | 62,500 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-12-30 | 2014-12-31 | 23,104 | $1.42 | $32.8K | 115,622 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-12-30 | 2014-12-31 | 23,104 | $12.06 | $278.6K | 92,518 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-12-29 | 2014-12-31 | 17,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-12-29 | 2014-12-31 | 14,396 | — | $0 | 85,604 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-12-29 | 2014-12-31 | 17,000 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-12-29 | 2014-12-31 | 17,000 | $5.45 | $92.7K | 183,417 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-12-29 | 2014-12-31 | 17,000 | $5.45 | $92.7K | 166,417 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2014-12-29 | 2014-12-31 | 105,295 | $12.43 | $1.31M | 92,518 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-12-29 | 2014-12-31 | 14,396 | $1.42 | $20.4K | 197,813 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-12-19 | 2014-12-23 | 17,000 | $5.45 | $92.7K | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-06-03 | 2014-06-05 | 3,427 | — | $0 | 46,573 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-06-03 | 2014-06-05 | 13,750 | — | $0 | 41,250 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2014-06-03 | 2014-06-05 | 4,051 | — | $0 | 59,949 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-06-03 | 2014-06-05 | 1,644 | $9.86 | $16.2K | 148,173 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-06-03 | 2014-06-05 | 3,427 | $4.73 | $16.2K | 149,817 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-06-03 | 2014-06-05 | 2,745 | $9.86 | $27.1K | 146,390 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-06-03 | 2014-06-05 | 4,051 | $6.68 | $27.1K | 149,135 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-06-03 | 2014-06-05 | 5,788 | $9.86 | $57.1K | 145,084 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2014-06-03 | 2014-06-05 | 13,750 | $4.15 | $57.1K | 150,872 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-05-26 | 2014-05-28 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-03-01 | 2014-03-07 | 1,739 | $11.69 | $20.3K | 137,122 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2014-01-20 | 2014-02-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2014-01-20 | 2014-02-04 | 54,000 | — | $0 | 136,539 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2014-01-01 | 2014-01-03 | 2,735 | $7.60 | $20.8K | 82,539 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise deriv | 2013-05-28 | 2013-05-29 | 16,407 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | M Exercise | 2013-05-28 | 2013-05-29 | 16,407 | $1.20 | $19.7K | 82,274 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2013-03-01 | 2013-03-06 | 1,789 | $1.19 | $2.1K | 62,867 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-31 | 2013-03-14 | 3,000 | $1.38 | $4.1K | 67,656 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2013-01-01 | 2013-01-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 8,500 | — | $0 | 56,156 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2013-01-01 | 2013-01-07 | 8,500 | — | $0 | 64,656 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-15 | 2012-03-19 | 22,869 | — | $0 | 52,199 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | F Tax w/h | 2012-03-15 | 2012-03-19 | 7,543 | $5.23 | $39.4K | 44,656 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-03-09 | 2012-03-12 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2012-03-02 | 2012-03-05 | 956 | $4.78 | $4.6K | 29,330 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | $4.73 | $236.5K | 50,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2012-03-01 | 2012-03-05 | 8,500 | — | $0 | 30,286 | SEC↗ |